Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41215| metadata.artigo.dc.title: | Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) |
| metadata.artigo.dc.creator: | Abedi, Farshad Rezaee, Ramin Karimi, Gholamreza |
| metadata.artigo.dc.subject: | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Rho kinase inhibitors |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Jun-2020 |
| metadata.artigo.dc.identifier.citation: | ABEDI, F.; REZAEE, R.; KARIMI, G. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). Pharmacological Research, [S.l.], v. 156, June 2020. |
| metadata.artigo.dc.description.abstract: | Indisponível. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S1043661820311166 http://repositorio.ufla.br/jspui/handle/1/41215 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.